CIIE Formula Launches Show Industry Reworking Old Playbooks

Summary

The ninth China International Import Expo (CIIE) ran from 5 to 10 November in Shanghai, with the food and nutrition zone hosting a dense cluster of new product launches. The a2 Milk Company rolled out three new infant formula products for the China market, Danone gave a global debut to its Nuquxing Youpei liquid formula, Herbalife's personalised nutrition product Bioniq GO made its Asia debut, MitoQ's cell essentials pure series had its Asia launch, and Arla Foods' premium Lunevia, not due to hit shelves until the first quarter of next year, also appeared early. The launches fall into three formulation routes.

The first is demographic segmentation, targeting specific physiological stages or needs, such as catch-up growth nutrition for children, mixed-feeding formulas, and probiotic strains aimed at metabolic health; the selling point is how well the product matches demand, but the addressable populations are small and repeat purchases depend on professional recommendation. The second is process upgrading, using new dosage forms or new ways of processing raw materials to improve the user experience, such as granule-technology nutrition supplements and liquid formula; the selling point is experience and convenience, but costs are high and price points are hard to push downmarket. The third is ingredient traceability, making origin, certification and ingredient sourcing the core selling point; the pitch rests on trust and premium pricing, but certification is costly and the selling point is easily copied.

The three routes carry different commercial implications: segmentation relies on professional channels and, once inside hospital or professional recommendation systems, delivers stable repeat purchases; process upgrading relies on experiential differentiation and can scale quickly on content platforms but is hard to defend on price; traceability suits long-term brand building but has weak short-term explosive power. National Bureau of Statistics data show 7.92 million births nationwide in 2025, a birth rate of 5.63 per mille, a marked decline from 9.54 million in 2024. The contraction of the infant formula base is pushing companies to take new products into finer scenarios such as mixed feeding, catch-up growth and metabolic health in search of incremental growth.

Commentary

The wave of infant formula launches at CIIE reflects a structural shift in China's infant nutrition market. Births fell to 7.92 million in 2025, shrinking the infant formula base and forcing companies to move from competition over total volume to mining segmented scenarios. New products from multinationals including a2, Danone and Herbalife are betting respectively on segmentation, process upgrading and ingredient traceability, essentially testing the conversion efficiency of different business models.

For New Zealand small and medium-sized enterprises, the trend is both a challenge and an opportunity. New Zealand dairy enjoys a reputation for natural, pure origins and has an inherent advantage in the traceability route, but certification costs are high and the selling point is easily imitated, so differentiated brand storytelling is needed to build barriers. The segmentation route depends on professional channels; New Zealand companies could consider partnering with local medical or nutrition institutions to enter niches such as catch-up growth for children and metabolic health, but must assess market size and channel entry costs.

Process upgrading demands heavy R&D investment; smaller firms could look at technology partnerships or contract manufacturing opportunities with larger players. Notably, Chinese consumers still place relatively high trust in imported nutrition products, but competition is intensifying and origin labelling alone is no longer enough to support a premium. New Zealand companies should match their own resources and choose one route to pursue in depth rather than following the crowd.

As a window on the direction of the China market, CIIE's new product logic is worth tracking to adjust product strategy and channel layout.

Keywords: CIIE, new product launches, infant formula, formulation routes, demographic segmentation, process upgrading, ingredient traceability, births, The a2 Milk Company, Danone


Photo from Unsplash (placeholder)

Source: bxtdata.com

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *